Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye Disease.
Andrea Lora KosslerRaymond DouglasChrysoula DosiouPublished in: The Journal of clinical endocrinology and metabolism (2022)
TED management is shifting to an era of targeted therapy with multidisciplinary care. Teprotumumab has demonstrated superior efficacy to conventional treatments and has transformed our therapeutic and surgical algorithms. Clinical guidelines and additional studies are needed to further guide and refine therapy.